The upcoming report from Garmin (GRMN) is expected to reveal quarterly earnings of $1.89 per share, indicating an increase of 9.9% compared to the year-ago period. Analysts forecast revenues of $1.67 billion, representing an increase of 12.7% year over year.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings r ...

All-in-one dive computer and smartwatch adds a bright AMOLED display for easy reading at any depth plus tools for life in and out of the waterOLATHE, Kan., Feb. 12, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the Descent™ G2, a rugged watch-style dive computer with features to help divers explore both their underwater and topside worlds. With support for multiple dive modes – ranging from technical diving to freediving – plus, popular features like a dive readiness score and Garmin's suite of h ...

Garmin (GRMN) closed the latest trading day at $215.73, indicating a -0.89% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.67%. At the same time, the Dow added 0.38%, and the tech-heavy Nasdaq gained 0.98%.The the stock of maker of personal navigation devices has risen by 4.07% in the past month, leading the Computer and Technology sector's loss of 0.79% and the S&P 500's gain of 2.07%.Investors will be eagerly watching for the performance of Garmin ...

First-of-its-kind HRM-Fit heart rate monitor for women lands Garmin among the top companies that are revolutionizing the health, fitness and wellness industryOLATHE, Kan., Feb. 6, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) has been recognized as one of the Most Innovative Fitness and Wellness Companies of 2025 by Athletech News. The award honors brands worldwide whose products, services and solutions are changing the health, fitness and wellness industry. Garmin earned the accolade for its innovative HRM- ...

Simplify life on the road and control functions throughout the RV using a sleek touchscreen display or completely hands-free with voice commandsOLATHE, Kan., Feb. 4, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced SERV+™ —the ultimate control panel for travelers who want a smart RV experience with a sleek, modern touchscreen display. Serving as command central for the RV, drivers and passengers can easily control onboard entertainment, monitor security camera feeds, change the temperature settings ...

Garmin (GRMN) , a global leader in wearable technology and GPS navigation, has been on a remarkable run with its consecutive product innovations, the latest being the Approach S44 and Approach S50 smartwatches that have a slim, light design and crucial features for golfers trying to improve their game.The new smartwatches are equipped with sharp 1.2-inch color AMOLED screens and come with preloaded maps of more than 43,000 golf courses and important golf functions like hazard view and distance to the front, ...

First-of-its-kind device offers distances to the green on a high-contrast screen and a solar-poweredbattery, allowing you to play round after round without chargingOLATHE, Kan., Jan. 21, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the Approach® G20 Solar, the first solar-powered GPS golf handheld that provides unlimited battery life when used in sunny conditions1. While on the course, golfers can see yardage to the front, middle and back of the green and plan their approach using the 2.2-inch h ...

Garmin (GRMN) has been successful in significant strides while demonstrating its ability to expand its market presence and capitalize on growing demand for its products.In a move to bolster its market reach, Garmin announced the availability of its ECG App in the Australian and European Union (EU) markets. The ECG App is now accessible and compatible with Garmin smartwatches, including Venu 3 Series, fenix 8 Series and more.The ECG app uses sensors on the user’s compatible smartwatch to record their heart r ...

Intuitive marine control panel adds an LED-backlit knob and button activation for more precise control in all sea conditionsOLATHE, Kan., Jan. 16, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN), the world's most innovative and recognized marine electronics manufacturer, today announced the new APK™ 10 Autopilot Keypad designed to give mariners more precise control of their Reactor™ 40 autopilot. The keypad features an LED-encircled rotary knob that allows for specific heading control, along with two autopilot but ...

Core Message - Garmin has launched an ECG App for compatible smartwatches in Australia and the European Union, enabling users to record heart rhythms and detect signs of atrial fibrillation (AFib) [1][2][3] Product Features - The ECG App allows users to record a 30-second ECG and view results immediately on the watch or via the Garmin Connect smartphone app [1] - The app uses sensors on compatible Garmin smartwatches to record electrical signals and analyze them for AFib signs [3] - Users can sync ECG results to Garmin Connect, view historical data, and create reports to share with healthcare providers [3] Regulatory and Availability - The ECG App is classified as a Class IIa medical device under the EU Medical Device Regulation (MDR) (EU) 2017/745 [6] - It is currently available in Australia and the European Union, with plans to expand to other regions pending regulatory approvals [4] - The app is compatible with select Garmin smartwatches, including the Venu 3 Series and fēnix 8 Series [1][6] Company Strategy - Garmin aims to continue expanding its portfolio of products supporting the ECG App and launching it in new regions [4] - The company emphasizes innovation in health and wellness, focusing on developing tools that help users lead healthier lives [5] Product Limitations - The ECG App is intended for adults aged 22 and over and is not a replacement for traditional diagnosis or treatment methods [6] - Users experiencing symptoms of serious cardiovascular conditions are advised to consult a doctor rather than relying solely on the device [6]